Moscoe brings extensive experience in life sciences and biotech, as well as thought leadership and a background in international business, to benefit Tunnell clients.

BERWYN, Pa. , July 1, 2024 /PRNewswire-PRWeb/ -- Tunnell, an employee-owned company that provides expert talent and consulting services to the Life Sciences industry, announced today that Steven Moscoe has joined the firm as its newest Principal.

Moscoe's diverse range of experience includes analysis of the impact of R&D, advanced therapy manufacturing and clinical and commercial projects on profitability, as well as identification of opportunities to expand services and collaborations.

"Over the course of my career, I have had an opportunity to work with clients to identify some of the industry's biggest challenges and to bring unique solutions to the table," said Moscoe. "Today as I embark on my new mission, I look forward to bringing expertise and insights to Tunnell Consulting's clients, and to work closely with the entire Tunnell team to create the best solutions for our clients."

Moscoe's diverse range of experience includes analysis of the impact of R&D, advanced therapy manufacturing and clinical and commercial projects on profitability, as well as identification of opportunities to expand services and collaborations. Additionally, his background as a Lean/Six Sigma practitioner has allowed him to provide insights for decision-making and execution across multiple projects. To further build on that strong foundation, Moscoe's communication and change management skills will prove essential in building strong and lasting partnerships with key stakeholders, clients and leadership.

Over his career, his projects have included leading program management for the build-out of a state-of-the-art CAR-T cell therapy manufacturing plant, managing complex programs for large pharmaceutical companies, and delivering projects across the U.S., Canada, Europe, LATAM, Asia and India.

Most recently Moscoe worked with life sciences venture capital (VC) and private equity (PE) clients delivering operational improvements for their portfolio companies, as well as providing buy and sell-side due diligence services. He has led multiple projects involving Contract Development & Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and Contract Packaging Organizations (CPOs), serving sponsor companies, contract organizations, and PE firms.

A respected thought leader who is published in the industry's leading journals, Moscoe earned his International MBA with Finance and French Business specialization at University of South Carolina, and his Bachelor of Business Administration at University of Kentucky. He has multiple certifications, including Certified Lean Practitioner, Six Sigma Black Belt, and Project Management Professional (PMP), as well as professional certifications from Emory, MIT, and Wharton.

About Tunnell Consulting

For over 60 years, Tunnell has provided both expert talent and consulting services to clients including Biopharmas, CDMOs, the US Government, incubators, investors and NGOs. We have experience across multiple platforms – including large molecule, vaccines, cell and gene therapy and small molecule – and our subject matter expertise focuses on regulatory, quality, GxP, pre-clinical/clinical, supply chain, manufacturing, CMC and product launch. To learn more, visit us online at http://www.tunnellconsulting.com.

Media Contact

Stephanie Haas, Tunnell Consulting, 1 (610) 337- 0820, stephanie.haase@tunnellconsulting.com , https://tunnellconsulting.com/ 

Cision View original content to download multimedia:https://www.prweb.com/releases/steven-moscoe-joins-tunnell-consulting-as-principal-bringing-extensive-life-sciences-expertise-302185407.html

SOURCE Tunnell Consulting

Copyright 2024 PR Newswire